Leronlimab (anti-CCR5)
Leronlimab (anti-CCR5) (PRO 140; Vyrologix)is a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy. It is being investigated as a potential therapy in the treatment of HIV infection.
Supplier | Selleck Chemicals |
---|---|
Product # | A2040 |
Sku # | A2040-1mg*25 |
Pricing | 1mg*25, $3237.00 |